The mechanism of inhibition of HIV-1 env-mediated cell-cell fusion by recombinant cores of gp41 ectodomain - PubMed (original) (raw)
. 2002 Oct 10;302(1):174-84.
doi: 10.1006/viro.2002.1593.
Affiliations
- PMID: 12429526
- DOI: 10.1006/viro.2002.1593
Free article
The mechanism of inhibition of HIV-1 env-mediated cell-cell fusion by recombinant cores of gp41 ectodomain
Ruben M Markosyan et al. Virology. 2002.
Free article
Abstract
N36(L6)C34 is a recombinant protein that forms a six-helix bundle with high thermal stability. It consists of the N-terminal heptad-repeat region (N36 peptide) and the C-terminal heptad-repeat region (C34) of HIV-1 gp41, connected by six polar amino acids. The protein inhibits HIV-1 envelope-induced membrane fusion. Whether inhibition occurs while N36(L6)C34 is in its six-helix bundle configuration was investigated. Mutating a critical residue within the N36 region to promote dissociation of C34 from the grooves of the N36 coiled coil reduced bundle stability and increased the inhibition of fusion. In contrast, mutating a key residue within the C34 region to reduce bundle stability decreased inhibitory potency. The data provide strong evidence that the proteins inhibit fusion while they expose their C34 segments, rather than as six-helix bundles. Thus, despite high thermal stability of the bundle, the recombinants' less folded structures are present in sufficient concentration to inhibit fusion at physiological temperatures.
Similar articles
- The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R. Gallo SA, et al. J Mol Biol. 2004 Jun 25;340(1):9-14. doi: 10.1016/j.jmb.2004.04.027. J Mol Biol. 2004. PMID: 15184018 - HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain.
Lu L, Tong P, Yu X, Pan C, Zou P, Chen YH, Jiang S. Lu L, et al. Biochim Biophys Acta. 2012 Dec;1818(12):2950-7. doi: 10.1016/j.bbamem.2012.07.020. Epub 2012 Jul 31. Biochim Biophys Acta. 2012. PMID: 22867851 - ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.
Yu F, Lu L, Liu Q, Yu X, Wang L, He E, Zou P, Du L, Sanders RW, Liu S, Jiang S. Yu F, et al. Biochim Biophys Acta. 2014 May;1838(5):1296-305. doi: 10.1016/j.bbamem.2013.12.022. Epub 2014 Jan 3. Biochim Biophys Acta. 2014. PMID: 24388952 - The C34 Peptide Fusion Inhibitor Binds to the Six-Helix Bundle Core Domain of HIV-1 gp41 by Displacement of the C-Terminal Helical Repeat Region.
Louis JM, Baber JL, Clore GM. Louis JM, et al. Biochemistry. 2015 Nov 17;54(45):6796-805. doi: 10.1021/acs.biochem.5b01021. Epub 2015 Nov 9. Biochemistry. 2015. PMID: 26506247 Free PMC article. - Multimerized HIV-gp41-derived peptides as fusion inhibitors and vaccines.
Nomura W, Mizuguchi T, Tamamura H. Nomura W, et al. Biopolymers. 2016 Nov 4;106(4):622-8. doi: 10.1002/bip.22782. Biopolymers. 2016. PMID: 26583370 Review.
Cited by
- A multivalent HIV-1 fusion inhibitor based on small helical foldamers.
Guarise C, Shinde S, Kibler K, Ghirlanda G, Prins LJ, Scrimin P. Guarise C, et al. Tetrahedron. 2012 Jun 10;68(23):4346-4352. doi: 10.1016/j.tet.2012.03.078. Epub 2012 Apr 7. Tetrahedron. 2012. PMID: 32287423 Free PMC article. - Swapped-domain constructs of the glycoprotein-41 ectodomain are potent inhibitors of HIV infection.
Chu S, Kaur H, Nemati A, Walsh JD, Partida V, Zhang SQ, Gochin M. Chu S, et al. ACS Chem Biol. 2015 May 15;10(5):1247-57. doi: 10.1021/cb501021j. Epub 2015 Feb 17. ACS Chem Biol. 2015. PMID: 25646644 Free PMC article. - A novel view of modelling interactions between synthetic and biological polymers via docking.
Tsvetkov VB, Serbin AV. Tsvetkov VB, et al. J Comput Aided Mol Des. 2012 Dec;26(12):1369-88. doi: 10.1007/s10822-012-9621-7. Epub 2012 Dec 13. J Comput Aided Mol Des. 2012. PMID: 23239170 - An inducible cell-cell fusion system with integrated ability to measure the efficiency and specificity of HIV-1 entry inhibitors.
Herschhorn A, Finzi A, Jones DM, Courter JR, Sugawara A, Smith AB 3rd, Sodroski JG. Herschhorn A, et al. PLoS One. 2011;6(11):e26731. doi: 10.1371/journal.pone.0026731. Epub 2011 Nov 1. PLoS One. 2011. PMID: 22069466 Free PMC article. - Amphipathic properties of HIV-1 gp41 fusion inhibitors.
Gochin M, Zhou G. Gochin M, et al. Curr Top Med Chem. 2011 Dec;11(24):3022-32. doi: 10.2174/156802611798808488. Curr Top Med Chem. 2011. PMID: 22044226 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources